ClinicalTrials.govpublic full text
First-in-human Safety and Tolerability of MP0317 in Patients With Relapsed/Refractory Advanced Solid Tumors
advanced malignant solid tumor, designed ankyrin repeat protein, darpin®, fibroblast activation protein, cd40 antigen, advanced malignant solid neoplasm, relapsed malignant solid neoplasm, refractory malignant solid neoplasm, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 850946
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.